Supplementary Figure 3 from Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068
3d. 9h

3d. 24h

18d. 2h

PR
RAS40 T246

Ak
kt S473

3d. 2h

Fig S3.
Yan /Serra et al

1.
